RFG Advisory LLC lifted its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 43,568 shares of the company’s stock after acquiring an additional 1,058 shares during the period. RFG Advisory LLC’s holdings in Procter & Gamble were worth $6,941,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in the business. Stableford Capital II LLC boosted its stake in Procter & Gamble by 1.1% in the 1st quarter. Stableford Capital II LLC now owns 5,817 shares of the company’s stock worth $993,000 after buying an additional 61 shares during the last quarter. B & T Capital Management DBA Alpha Capital Management boosted its stake in Procter & Gamble by 2.3% in the 1st quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company’s stock worth $476,000 after buying an additional 63 shares during the last quarter. Private Management Group Inc. boosted its stake in Procter & Gamble by 4.8% in the 1st quarter. Private Management Group Inc. now owns 1,384 shares of the company’s stock worth $236,000 after buying an additional 64 shares during the last quarter. Lantz Financial LLC boosted its stake in Procter & Gamble by 1.2% in the 2nd quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock worth $834,000 after buying an additional 64 shares during the last quarter. Finally, Orca Investment Management LLC boosted its stake in Procter & Gamble by 2.0% in the 2nd quarter. Orca Investment Management LLC now owns 3,238 shares of the company’s stock worth $516,000 after buying an additional 64 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Stock Performance
Procter & Gamble stock opened at $147.54 on Tuesday. The stock’s 50 day moving average price is $155.18 and its 200 day moving average price is $159.27. The firm has a market capitalization of $345.32 billion, a PE ratio of 22.66, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a one year low of $146.96 and a one year high of $180.43.
Insider Activity
In other Procter & Gamble news, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the sale, the chief financial officer directly owned 52,642 shares in the company, valued at $8,279,007.34. The trade was a 18.11% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the sale, the insider owned 182,422 shares in the company, valued at $28,689,507.94. This represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock worth $23,421,279 in the last ninety days. 0.20% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
PG has been the topic of a number of research analyst reports. Bank of America decreased their price target on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Berenberg Bank lifted their price objective on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research note on Wednesday, September 17th. Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Wells Fargo & Company reduced their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research note on Thursday, September 25th. Finally, BNP Paribas reaffirmed an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus price target of $172.21.
Check Out Our Latest Research Report on Procter & Gamble
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
- Five stocks we like better than Procter & Gamble
- The How And Why of Investing in Oil Stocks
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- What is a Dividend King?
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- What Investors Need to Know About Upcoming IPOs
- Datavault: A Speculative AI Play, But Beware of Volatility
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.